WPS Analyst Ratings
Strong Buy
8 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
WPS Stock 12 Month Forecast
Average Price Target
―| Highest Price TargetCHF365.90 | Average Price TargetCHF329.68 | Lowest Price TargetCHF298.78 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Evercore ISI
CHF335.62→CHF347.89
Buy
―
Reiterated
07/27/26
Barclays
CHF327.43
Buy
―
Reiterated
07/24/26
Bank of America Securities
CHF335.62
Buy
―
Reiterated
07/24/26
TD Cowen
CHF298.78→CHF335.62
Buy
―
Assigned
07/23/26
William Blair
―
Buy
―
Reiterated
07/23/26
Exane BNP Paribas
CHF365.9
Buy
―
Initiated
07/13/26
Morgan Stanley
CHF266.04→CHF298.78
Hold
―
Assigned
07/09/26
KeyBanc
CHF286.5→CHF319.24
Buy
―
Reiterated
07/02/26
Wolfe Research
CHF306.97
Buy
―
Assigned
06/01/26
Citi
CHF306.97→CHF327.43
Buy
―
Reiterated
04/24/26
RBC Capital
CHF290.59→CHF278.32
Buy
―
Reiterated
02/13/26
Deutsche Bank
CHF253.76→CHF257.85
Buy
―
Reiterated
02/13/26
Jefferies
CHF298.78→CHF241.48
Buy
―
Reiterated
02/10/26
DBS
CHF261.94
Buy
―
Reiterated
01/28/26
Nephron
CHF300.42
Buy
―
Upgraded
12/11/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Evercore ISI
CHF335.62→CHF347.89
Buy
―
Reiterated
07/27/26
Barclays
CHF327.43
Buy
―
Reiterated
07/24/26
Bank of America Securities
CHF335.62
Buy
―
Reiterated
07/24/26
TD Cowen
CHF298.78→CHF335.62
Buy
―
Assigned
07/23/26
William Blair
―
Buy
―
Reiterated
07/23/26
Exane BNP Paribas
CHF365.9
Buy
―
Initiated
07/13/26
Morgan Stanley
CHF266.04→CHF298.78
Hold
―
Assigned
07/09/26
KeyBanc
CHF286.5→CHF319.24
Buy
―
Reiterated
07/02/26
Wolfe Research
CHF306.97
Buy
―
Assigned
06/01/26
Citi
CHF306.97→CHF327.43
Buy
―
Reiterated
04/24/26
RBC Capital
CHF290.59→CHF278.32
Buy
―
Reiterated
02/13/26
Deutsche Bank
CHF253.76→CHF257.85
Buy
―
Reiterated
02/13/26
Jefferies
CHF298.78→CHF241.48
Buy
―
Reiterated
02/10/26
DBS
CHF261.94
Buy
―
Reiterated
01/28/26
Nephron
CHF300.42
Buy
―
Upgraded
12/11/25
Best Analysts Covering West Pharmaceutical Services
3 Months
Success Rate
7/10 ratings generated profit
Average Return
+12.42%
reiterated a buy rating 10 days ago
Copying Matt Larew's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +12.42% per trade.
1 Year
Success Rate
6/7 ratings generated profit
Average Return
+20.67%
reiterated a buy rating 3 months ago
Copying Patrick B Donnelly's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +20.67% per trade.
2 Years
Success Rate
6/6 ratings generated profit
Average Return
+31.57%
reiterated a buy rating 6 months ago
Copying Dan Leonard's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +31.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
WPS Analyst Recommendation Trends
Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
2
1
1
0
0
Buy
25
45
40
52
77
Hold
14
15
12
15
17
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
41
61
53
67
94
Each month's total comprises the sum of three months' worth of ratings.
WPS Financial Forecast
WPS Stock Forecast FAQ
What is CH:WPS’s average 12-month price target, according to analysts?
Based on analyst ratings, West Pharmaceutical Services, Inc.’s 12-month average price target is 329.68.
What is CH:WPS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:WPS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is West Pharmaceutical Services, Inc. a Buy, Sell or Hold?
West Pharmaceutical Services, Inc. has a consensus rating of Strong Buy, which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
What is West Pharmaceutical Services, Inc.’s share price target?
The average share price target for West Pharmaceutical Services, Inc. is 329.68. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF365.90 ,and the lowest forecast is CHF298.78. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is CHF365.90 ,and the lowest forecast is CHF298.78. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about West Pharmaceutical Services, Inc.?
West Pharmaceutical Services, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of West Pharmaceutical Services, Inc.?
To buy shares of CH:WPS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.